PATIENT PREFERENCES FOR ATTRIBUTES OF TYPE 2 DIABETES MELLITUS (T2DM) TREATMENTS IN SPAIN

被引:0
|
作者
Mansfield, C. A. [1 ]
Sikirica, M. [2 ]
Pugh, A. [1 ]
Poulos, C. [1 ]
Martin, A. A. [3 ]
Ruiz Moran, L. [4 ]
Morano Larragueta, R. [4 ]
机构
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] GlaxoSmithKline, King Of Prussia, PA USA
[3] GlaxoSmithKline, Uxbridge, Middx, England
[4] GlaxoSmithKline, Madrid, Spain
关键词
D O I
10.1016/j.jval.2015.09.2134
中图分类号
F [经济];
学科分类号
02 ;
摘要
PDB94
引用
收藏
页码:A614 / A614
页数:1
相关论文
共 50 条
  • [1] PATIENT'S AND PROFESSIONAL'S PREFERENCES FOR TYPE 2 DIABETES MELLITUS TREATMENTS (T2DM) IN SPAIN AND PORTUGAL. A DISCRETE CHOICE EXPERIMENT
    Morillas, C.
    Feliciano, R.
    Catalina, Fernandez P.
    Ponte, C.
    Botella, M.
    Rodrigues, J.
    Esmatjes, E.
    Lafita, J.
    Lizan, L.
    Llorente, I
    Morales, C.
    Navarro, J.
    Orozco, D.
    Paz, S.
    de Suarez M, Tribaldos
    de Arellano A, Ramirez
    Cardoso, C.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A66 - A66
  • [2] Patient preferences for attributes of type 2 diabetes mellitus treatments in Germany
    Sikirica, M.
    Mansfield, C.
    Pugh, A.
    Poulos, C.
    Martin, A.
    Unmuessig, V.
    [J]. DIABETOLOGIA, 2015, 58 : S348 - S348
  • [3] IMPACT OF PATIENT WEIGHT TRAJECTORY ON COST-EFFECTIVENESS OF TREATMENTS OF TYPE 2 DIABETES MELLITUS (T2DM)
    Schroeder, M.
    Willis, M.
    Johansen, P.
    Girod, I
    Neslusan, C.
    Thompson, G.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A440 - A440
  • [4] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [6] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [7] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [8] EFFICACY AND SAFETY OF TREATMENTS OF TYPE 2 DIABETES MELLITUS (T2DM): A SYSTEMATIC REVIEW (SLR)
    Pettre, S.
    Selya-Hammer, C.
    Ho, S.
    Garg, M.
    Schroeder, M.
    Kaur, V
    Hemels, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A433 - A433
  • [9] A patient with Type 2 Diabetes Mellitus (T2DM) with Fournier gangrene: a case report
    Christanti, Mike
    Prajitno, Jongky Hendro
    Christanto, Rio Yudistira
    [J]. BALI MEDICAL JOURNAL, 2022, 11 (01) : 61 - 66
  • [10] THE PREVALENCE OF MICROALBUMINURIA IN CHILDREN WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Yafi, Michael
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A250 - A250